Pressure BioSciences (PBIO) Posts Q3 Loss of $0.35, Misses by 2c
More News related to PBIO
- UMass Boston's Venture Development Center Announces New Bio-Science Partner
- Pressure BioSciences (PBIO) Issued Five Additional PCT Patents
- Pressure BioSciences, Inc. Granted Five Additional Patents
- Pressure BioSciences, Inc. to Present at the OneMedPlace Financial Forum 2010 and the Biotech Showcase 2010 Investor Conferences
- Pressure BioSciences (PBIO) Posts Q3 Loss of $0.35, Misses by 2c
More News related to Earnings
- Highlights From ERTS's Q3 Conference Call: Releasing Several New Titles, But Guides Below Street Consensus
- Coca-Cola (KO) Q4 Profits Surge, Helped by Emerging Markets
- Versar (VSR) Swings to Q2 Loss of $0.03
- Martin Marietta Materials (MLM) Swings to Q4 Loss of $0.07
- RG Barry (DFZ) Posts Q2 EPS of $0.74, Beats by 9c
Pressure BioSciences (NASDAQ: PBIO) reports Q3 loss of $0.35, versus the analyst estimate of ($0.33). Revenue for the quarter was $317,427, which compares to the estimate of $480,000.
Related Categories
EarningsStocks Mentioned
+0.16Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
